Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 13,897 | 181 | 4,563 | 0 | 274 |
| Cost of Goods | 3,305 | 35 | 613 | N/A | N/A |
| Gross Profit | 10,592 | 146 | 3,950 | N/A | 274 |
| Operating Expenses | 91,455 | 26,296 | 56,707 | 17,576 | 0 |
| Operating Income | -80,558 | -26,115 | -52,144 | -17,576 | 274 |
| Interest Expense | 3,326 | 3,429 | 2,418 | 1,371 | 0 |
| Other Income | 1,462 | 66 | -1,036 | -998 | 0 |
| Pre-tax Income | -82,422 | -29,478 | -55,598 | -19,945 | 274 |
| Net Income Continuous | -82,422 | -29,478 | -55,598 | -19,945 | 274 |
| Net Income | $-82,422 | $-29,478 | $-55,598 | $-19,945 | $274 |
| EPS Basic Total Ops | -1.28 | -0.46 | -0.86 | -0.31 | N/A |
| EPS Basic Continuous Ops | -1.28 | -0.46 | -0.86 | -0.31 | N/A |
| EPS Diluted Total Ops | -1.28 | -0.46 | -0.86 | -0.31 | N/A |
| EPS Diluted Continuous Ops | -1.28 | -0.46 | -0.86 | -0.31 | N/A |
| EBITDA(a) | $-74,799 | $-23,959 | $-48,971 | $-15,385 | $2,789 |